Imago BioSciences to Present Updated Data from Phase 2 Studies of Bomedemstat for the Treatment of Essential Thrombocythemia and Myelofibrosis at 2021 European Hematology Association Virtual Congress

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #Bomedemstat--Imago BioSciences to Present Updated Data from Phase 2 Studies of Bomedemstat for Treatment of Essential Thrombocythemia & Myelofibrosis at #EHA2021

Click to view original post